A comparative evaluation of the therapeutic effect of pyrantel pamoate and bepenium hydroxynaphthoate on Ancylostoma duodenale and other intestinal helminths.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000724:Ancylostomiasis / Q000188:drug therapy*; D000871:Anthelmintics / Q000009:adverse effects / Q000627:therapeutic use*; D001196:Ascariasis / Q000188:drug therapy; D001598:Bephenium Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004757:Enterobius / Q000187:drug effects; D005243:Feces; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007492:Iran; D008297:Male; D008875:Middle Aged; D010270:Parasite Egg Count; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*; D014252:Trichostrongyloidiasis / Q000188:drug therapy
D000871:Anthelmintics; D001598:Bephenium Compounds; D011743:Pyrimidines